Literature DB >> 10622569

Mother-to-infant transmission of hepatitis C virus.

A R Zanetti1, E Tanzi, M L Newell.   

Abstract

The rate of mother-to-infant transmission of hepatitis C virus (HCV) is approximately 5%, but is higher when the mother is co-infected with HIV Vertical transmission is restricted to infants whose mothers are viraemic. The risk of transmission increases with increasing maternal viral load but a specific cut-off value predicting infection cannot be defined. There is no specific HCV genotype which is preferentially transmitted. The mode of delivery (caesarean versus vaginal) does not appear to influence the rate of transmission, but firm evidence is lacking. There is no evidence to suggest an increased risk of HCV transmission through breast feeding. Pregnancy is not contra-indicated in HCV-infected women. Without drugs to treat established infections in mothers and infants and interventions to prevent vertical transmission, routine HCV screening is not recommended in pregnant women.

Entities:  

Mesh:

Year:  1999        PMID: 10622569     DOI: 10.1016/s0168-8278(99)80383-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

Review 1.  Laboratory assays for diagnosis and management of hepatitis C virus infection.

Authors:  Sandra S Richter
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 2.  Vertical hepatitis C virus transmission: Main questions and answers.

Authors:  Grazia Tosone; Alberto Enrico Maraolo; Silvia Mascolo; Giulia Palmiero; Orsola Tambaro; Raffaele Orlando
Journal:  World J Hepatol       Date:  2014-08-27

Review 3.  Hepatitis B and C in pregnancy: a review and recommendations for care.

Authors:  J C Dunkelberg; E M F Berkley; K W Thiel; K K Leslie
Journal:  J Perinatol       Date:  2014-09-18       Impact factor: 2.521

4.  Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection.

Authors:  A Manzin; L Solforosi; M Debiaggi; F Zara; E Tanzi; L Romanò; A R Zanetti; M Clementi
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 5.  Hepatitis C in pregnancy.

Authors:  Grace L Su
Journal:  Curr Gastroenterol Rep       Date:  2005-02

6.  Mother-to-Child Transmission of Hepatitis C Virus (HCV) Among HIV/HCV-Coinfected Women.

Authors:  Claudia A Checa Cabot; Sonia K Stoszek; Jorge Quarleri; Marcelo H Losso; Silvina Ivalo; Mario F Peixoto; José H Pilotto; Horacio Salomon; Leon C Sidi; Jennifer S Read
Journal:  J Pediatric Infect Dis Soc       Date:  2012-10-11       Impact factor: 3.164

7.  Innate immune function in placenta and cord blood of hepatitis C--seropositive mother-infant dyads.

Authors:  Christine Waasdorp Hurtado; Lucy Golden-Mason; Megan Brocato; Mona Krull; Michael R Narkewicz; Hugo R Rosen
Journal:  PLoS One       Date:  2010-08-30       Impact factor: 3.240

8.  Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand.

Authors:  Nicole Ngo-Giang-Huong; Gonzague Jourdain; Wasna Sirirungsi; Luc Decker; Woottichai Khamduang; Sophie Le Coeur; Surat Sirinontakan; Rosalin Somsamai; Karin Pagdi; Jittapol Hemvuttiphan; Kenneth McIntosh; Francis Barin; Marc Lallemant
Journal:  Int J Infect Dis       Date:  2010-01-03       Impact factor: 3.623

9.  Hepatitis C Virus Sensing by Human Trophoblasts Induces Innate Immune Responses and Recruitment of Maternal NK Cells: Potential Implications for Limiting Vertical Transmission.

Authors:  Silvia Giugliano; Margaret G Petroff; Bryce D Warren; Susmita Jasti; Caitlin Linscheid; Ashley Ward; Anita Kramer; Evgenia Dobrinskikh; Melissa A Sheiko; Michael Gale; Lucy Golden-Mason; Virginia D Winn; Hugo R Rosen
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

10.  Host factors that influence mother-to-child transmission of HIV-1: genetics, coinfections, behavior and nutrition.

Authors:  Sascha R Ellington; Caroline C King; Athena P Kourtis
Journal:  Future Virol       Date:  2011-11-24       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.